This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Central nervous system
Central nervous system
Mundipharma launches Remsima®, a new-generation value-based monoclonal antibody
Treeway B.V. and LACDR collaborate on ALS therapy development
Bayer remains committed to supporting NHS with improved access to Sativex®
Roche initiates phase III trials for lampalizumab, first potential treatment for geographic atrophy
Sativex® recommended by the AWMSG
Ebola victims include pharmacy professionals
acapella® choice helps cystic fibrosis patients
First treatment approved for multicentric Castleman’s disease in Europe
Management of cystic fibrosis
Bexsero® to protect students against potentially deadly meningitis B
The changing fortunes of dimethyl fumarate
A new test for meningitis
« Previous
1
2
3
4
5
6
…
28
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: